| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 1984 Oxford University Press
research-article |
HDL Serum Cholesterol and 24–Year Mortality of Men in Finland
*Laboratory of Physiological Hygiene, University of Minnesota School of Public Health Minneapolis, Minnesota, USA.
**Cardiovascular Diseases Unit, World Health Organization Geneva, Switzerland
Research Department, Finnish Heart Association Helsinki, Finland
Laboratory of Epidemiology and Biostatistics, Istituto Superiore di Sanita Rome, Italy
Istituto di Scienza della Alimentazione, University of Perugia Perugia, Italy
Keys A (Laboratory of Physiological Hygiene, University of Minnesota School of Public Health, Minneapolis, Minnesota, USA), Karvonen M J, Punsar S, Menotti A, Fidanza F and Farchi G. HDL serum cholesterol and 24-year mortality of men in Finland. International Journal of Epidemiology 1984, 13: 428–435.
Examinations of ‘healthy’ men in Helsinki and in rural west and east Finland in 1956 included estimation of total cholesterol and that in the HDL and beta fractions separated by electrophoresis. Vital status to the end of 1980 has been ascertained for all but eight of the 526 men aged 35–61 and for all but two of 261 men aged 30–34 at entry. Among the men aged 35–61, in 24 years 155 died, 63 from coronary heart disease; among the men aged 30–34, 36 died, 16 from coronary heart disease. All causes and coronary death rates were highest in east Finland where HDL cholesterol was also highest. Coronary death rates were not related to HDL cholesterol in east or west Finland but 16 men dead from coronary heart disease in Helsinki tended to have low HDL values. Consideration of five other entry characteristics did not change the picture with regard to HDL–mortality relationships. Solution of the multiple logistic equation using all those variables found the probability of 24-year coronary death was not significantly related to HDL but was significantly related, positively, to the non-HDL cholesterol concentration. HDL and total cholesterol mean values for men of the same age in the same area of Finland, with lipoprotein separation by the new recommended methods, agree closely with the means recorded in 1956. These 24-year findings are not necessarily in conflict with reports in the literature on an inverse relationship between coronary heart disease incidence and HDL cholesterol based on much shorter periods of follow-up and few data on mortality.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. H. Hsia Non-HDL Cholesterol: Into the Spotlight Diabetes Care, January 1, 2003; 26(1): 240 - 242. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Bittner, R. Hardison, S. F. Kelsey, B. H. Weiner, A. K. Jacobs, and G. Sopko Non-High-Density Lipoprotein Cholesterol Levels Predict Five-Year Outcome in the Bypass Angioplasty Revascularization Investigation (BARI) Circulation, November 12, 2002; 106(20): 2537 - 2542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Cui, R. S. Blumenthal, J. A. Flaws, M. K. Whiteman, P. Langenberg, P. S. Bachorik, and T. L. Bush Non-High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality Arch Intern Med, June 11, 2001; 161(11): 1413 - 1419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Zema Gemfibrozil, nicotinic acid and combination therapy in patients with isolated hypoalphalipoproteinemia: a randomized, open-label, crossover study J. Am. Coll. Cardiol., March 1, 2000; 35(3): 640 - 646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Catalano, E. Perilli, G. Carzaniga, G. Scandale, and M. Carotta Arterial Damage, Triglycerides, Apolipoprotein, and Lp-(a) Values in PVD Patients Clinical and Applied Thrombosis/Hemostasis, April 1, 1997; 3(2): 104 - 109. [Abstract] [PDF]
|
|
|
|
|
|
G. L. Vega and S. M. Grundy Lipoprotein Responses to Treatment With Lovastatin, Gemfibrozil, and Nicotinic Acid in Normolipidemic Patients With Hypoalphalipoproteinemia Arch Intern Med, January 10, 1994; 154(1): 73 - 82. [Abstract] [PDF]
|
|
|
|
 |
|
 G. L. Vega and S. M. Grundy Comparison of Lovastatin and Gemfibrozil in Normolipidemic Patients With Hypoalphalipoproteinemia JAMA, December 8, 1989; 262(22): 3148 - 3153. [Abstract] [PDF]
|
|
|
|
|
|
S. M. Grundy, D. S. Goodman, B. M. Rifkind, and J. I. Cleeman The Place of HDL in Cholesterol Management: A Perspective From the National Cholesterol Education Program Arch Intern Med, March 1, 1989; 149(3): 505 - 510. [Abstract] [PDF]
|
|
|
|
|
|
D. Kromhout, E. B. Bosschieter, M. Drijver, and C. d. L. Coulander Serum Cholesterol and 25-Year Incidence of and Mortality From Myocardial Infarction and Cancer: The Zutphen Study Arch Intern Med, May 1, 1988; 148(5): 1051 - 1055. [Abstract] [PDF]
|
|
|
|
|
|
W. P. Castelli, R. J. Garrison, P. W. F. Wilson, R. D. Abbott, S. Kalousdian, and W. B. Kannel Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels: The Framingham Study JAMA, November 28, 1986; 256(20): 2835 - 2838. [Abstract] [PDF]
|
|